thiotepa has been researched along with Carcinoma, Oat Cell in 3 studies
Thiotepa: A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albain, KS | 1 |
| Crowley, JJ | 2 |
| Hutchins, L | 1 |
| Gandara, D | 1 |
| O'Bryan, RM | 2 |
| Von Hoff, DD | 1 |
| Griffin, B | 1 |
| Livingston, RB | 2 |
| Kim, PN | 1 |
| Epstein, RB | 1 |
| Neilan, B | 1 |
| Coltman, CA | 1 |
| Stuckey, WJ | 1 |
| Pazdur, R | 1 |
1 review available for thiotepa and Carcinoma, Oat Cell
| Article | Year |
|---|---|
Chemotherapy of solid tumors. Recent advances.
Topics: Adult; Alkylating Agents; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Bronchogenic; Carcinom | 1976 |
2 trials available for thiotepa and Carcinoma, Oat Cell
| Article | Year |
|---|---|
Predictors of survival following relapse or progression of small cell lung cancer. Southwest Oncology Group Study 8605 report and analysis of recurrent disease data base.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide | 1993 |
Comparison of etoposide and cisplatin with bis-chloro-ethylnitrosourea, thiotepa, vincristine, and cyclophosphamide for salvage treatment in small cell lung cancer. A Southwest Oncology Group Study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Carmustine; Cisp | 1990 |